FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
University of British Columbia
Vancouver, CanadáPublicaciones en colaboración con investigadores/as de University of British Columbia (28)
2024
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
2023
-
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease
Nature Cardiovascular Research, Vol. 2, Núm. 2, pp. 144-158
2022
-
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
Respiratory Medicine, Vol. 200
2021
-
Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism
American Journal of Human Genetics, Vol. 108, Núm. 6, pp. 1138-1150
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
-
Treatment of Multisystem Inflammatory Syndrome in Children
New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22
2020
-
Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial
Calcified Tissue International, Vol. 106, Núm. 6, pp. 646-654
-
Efficacy and Safety of Trastuzumab Emtansine plus Capecitabine vs Trastuzumab Emtansine Alone in Patients with Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Phase 1 and Randomized Phase 2 Trial
JAMA Oncology, Vol. 6, Núm. 8, pp. 1203-1209
-
Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial
Osteoporosis International, Vol. 31, Núm. 10, pp. 1935-1942
-
Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants
Genetics in Medicine, Vol. 22, Núm. 8, pp. 1338-1347
-
Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use"
Journal of Clinical Endocrinology and Metabolism
-
Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling
Biological Psychiatry, Vol. 87, Núm. 2, pp. 100-112
-
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial
Bone, Vol. 130
2019
-
Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis
Bone, Vol. 120, pp. 1-8
-
Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial
Archives of Osteoporosis, Vol. 14, Núm. 1
2018
-
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
Journal of Bone and Mineral Research, Vol. 33, Núm. 5, pp. 783-794
-
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
The Lancet, Vol. 391, Núm. 10117, pp. 230-240
-
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course 06 Biological Sciences 0604 Genetics 11 Medical and Health Sciences 1109 Neurosciences
Journal of Neuroinflammation, Vol. 15, Núm. 1
-
Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer
European Journal of Cancer, Vol. 89, pp. 27-35
-
Teriparatide vs risedronate for osteoporosis – Authors' reply
The Lancet